Vancouver-based Absci to send first drug to clinical trials in what CEO calls a ‘huge milestone’ The Citizen 1 year ago Absci is preparing to send its first internally developed drug to clinical trials. Read more… Source: The Columbian Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Share on Pinterest (Opens in new window) Pinterest Share on WhatsApp (Opens in new window) WhatsApp Just months after public offering, Absci heading for clinical trials with a biologic drug candidateDateMay 14, 2024In relation toAbsciVancouver biotech firm Absci inks 10 deals for drug discovery programs worth $1 billionDateDecember 23, 2023In relation toBusinessAbsci announces new partnership, records loss for Q3DateNovember 16, 2023In relation toBusiness
